Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Successful in utero stem cell transplantation in X-linked severe combined immunodeficiency.

Magnani A, Jouannic JM, Rosain J, Gabrion A, Touzot F, Roudaut C, Kracker S, Mahlaoui N, Toubert A, Clave E, Macintyre EA, Radford-Weiss I, Alcantara M, Magrin E, Ternaux B, Nisoy J, Caccavelli L, Darras AM, Picard C, Blanche S, Cavazzana M.

Blood Adv. 2019 Feb 12;3(3):237-241. doi: 10.1182/bloodadvances.2018023176. No abstract available.

2.

Naïve CD8+ T-Cells Engage a Versatile Metabolic Program Upon Activation in Humans and Differ Energetically From Memory CD8+ T-Cells.

Nicoli F, Papagno L, Frere JJ, Cabral-Piccin MP, Clave E, Gostick E, Toubert A, Price DA, Caputo A, Appay V.

Front Immunol. 2018 Dec 21;9:2736. doi: 10.3389/fimmu.2018.02736. eCollection 2018.

3.

Human thymopoiesis is influenced by a common genetic variant within the TCRA-TCRD locus.

Clave E, Araujo IL, Alanio C, Patin E, Bergstedt J, Urrutia A, Lopez-Lastra S, Li Y, Charbit B, MacPherson CR, Hasan M, Melo-Lima BL, Douay C, Saut N, Germain M, Trégouët DA, Morange PE, Fontes M, Duffy D, Di Santo JP, Quintana-Murci L, Albert ML, Toubert A; Milieu Intérieur Consortium.

Sci Transl Med. 2018 Sep 5;10(457). pii: eaao2966. doi: 10.1126/scitranslmed.aao2966.

PMID:
30185651
4.

Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis.

Arruda LCM, Lima-Júnior JR, Clave E, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Covas DT, Simões BP, Farge D, Toubert A, Malmegrim KCR, Oliveira MC.

Bone Marrow Transplant. 2018 Oct;53(10):1319-1327. doi: 10.1038/s41409-018-0162-0. Epub 2018 Apr 18.

PMID:
29670207
5.

Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients.

Arruda LCM, Malmegrim KCR, Lima-Júnior JR, Clave E, Dias JBE, Moraes DA, Douay C, Fournier I, Moins-Teisserenc H, Alberdi AJ, Covas DT, Simões BP, Lansiaux P, Toubert A, Oliveira MC.

Blood Adv. 2018 Jan 23;2(2):126-141. doi: 10.1182/bloodadvances.2017011072.

6.

Long-term immune reconstitution and T cell repertoire analysis after autologous hematopoietic stem cell transplantation in systemic sclerosis patients.

Farge D, Arruda LC, Brigant F, Clave E, Douay C, Marjanovic Z, Deligny C, Maki G, Gluckman E, Toubert A, Moins-Teisserenc H.

J Hematol Oncol. 2017 Jan 19;10(1):21. doi: 10.1186/s13045-016-0388-5.

7.

Alterations of circulating lymphoid committed progenitor cellular metabolism after allogeneic stem cell transplantation in humans.

Glauzy S, Peffault de Latour R, André-Schmutz I, Lachuer J, Servais S, Socié G, Clave E, Toubert A.

Exp Hematol. 2016 Sep;44(9):811-816.e3. doi: 10.1016/j.exphem.2016.05.008. Epub 2016 Jun 17.

PMID:
27321893
8.

Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases.

Arruda LC, Clave E, Moins-Teisserenc H, Douay C, Farge D, Toubert A.

Curr Res Transl Med. 2016 Apr-Jun;64(2):107-13. doi: 10.1016/j.retram.2016.03.004. Epub 2016 Jun 1. Review.

PMID:
27316394
9.

Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients.

Alanio C, Nicoli F, Sultanik P, Flecken T, Perot B, Duffy D, Bianchi E, Lim A, Clave E, van Buuren MM, Schnuriger A, Johnsson K, Boussier J, Garbarg-Chenon A, Bousquet L, Mottez E, Schumacher TN, Toubert A, Appay V, Heshmati F, Thimme R, Pol S, Mallet V, Albert ML.

Elife. 2015 Nov 14;4. pii: e07916. doi: 10.7554/eLife.07916.

10.

Impact of acute and chronic graft-versus-host disease on human B-cell generation and replication.

Glauzy S, Soret J, Fournier I, Douay C, Moins-Teisserenc H, Peffault de Latour R, Maki G, Robin M, Socié G, Toubert A, Clave E.

Blood. 2014 Oct 9;124(15):2459-62. doi: 10.1182/blood-2014-05-573303. Epub 2014 Sep 2.

11.

CD158k is a reliable marker for diagnosis of Sézary syndrome and reveals an unprecedented heterogeneity of circulating malignant cells.

Moins-Teisserenc H, Daubord M, Clave E, Douay C, Félix J, Marie-Cardine A, Ram-Wolff C, Maki G, Beldjord K, Homyrda L, Michel L, Bensussan A, Toubert A, Bagot M.

J Invest Dermatol. 2015 Jan;135(1):247-257. doi: 10.1038/jid.2014.356. Epub 2014 Aug 26.

12.

Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction.

Yap M, Boeffard F, Clave E, Pallier A, Danger R, Giral M, Dantal J, Foucher Y, Guillot-Gueguen C, Toubert A, Soulillou JP, Brouard S, Degauque N.

J Am Soc Nephrol. 2014 Aug;25(8):1856-68. doi: 10.1681/ASN.2013080848. Epub 2014 Mar 20.

13.

CXCR4-related increase of circulating human lymphoid progenitors after allogeneic hematopoietic stem cell transplantation.

Glauzy S, André-Schmutz I, Larghero J, Ezine S, Peffault de Latour R, Moins-Teisserenc H, Servais S, Robin M, Socié G, Clave E, Toubert A.

PLoS One. 2014 Mar 12;9(3):e91492. doi: 10.1371/journal.pone.0091492. eCollection 2014.

14.

Tc1 clonal T cell expansion during chronic graft-versus-host disease-associated hypereosinophilia.

Clave E, Xhaard A, Douay C, Adès L, Cayuela JM, Peffault de Latour R, Robin M, Toubert A, Socié G.

Biol Blood Marrow Transplant. 2014 May;20(5):739-42. doi: 10.1016/j.bbmt.2014.01.023. Epub 2014 Jan 24.

15.

Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.

Servais S, Lengline E, Porcher R, Carmagnat M, Peffault de Latour R, Robin M, Sicre de Fontebrune F, Clave E, Maki G, Granier C, Xhaard A, Dhedin N, Molina JM, Toubert A, Moins-Teisserenc H, Socie G.

Biol Blood Marrow Transplant. 2014 Apr;20(4):507-17. doi: 10.1016/j.bbmt.2014.01.001. Epub 2014 Jan 7.

16.

Lenalidomide consolidation and maintenance therapy after autologous stem cell transplant for multiple myeloma induces persistent changes in T-cell homeostasis.

Clave E, Douay C, Coman T, Busson M, Bompoint C, Moins-Teisserenc H, Glauzy S, Carmagnat M, Gorin NC, Toubert A, Garderet L.

Leuk Lymphoma. 2014 Aug;55(8):1788-95. doi: 10.3109/10428194.2013.865182. Epub 2013 Dec 31.

PMID:
24237448
17.

Oligoclonal expansions of mucosal T cells in Crohn's disease predominate in NKG2D-expressing CD4 T cells.

Camus M, Esses S, Pariente B, Le Bourhis L, Douay C, Chardiny V, Mocan I, Benlagha K, Clave E, Toubert A, Mayer L, Allez M.

Mucosal Immunol. 2014 Mar;7(2):325-34. doi: 10.1038/mi.2013.51. Epub 2013 Aug 14.

PMID:
23945543
18.

In situ chimerism after double cord blood transplantation.

Labussière H, Loiseau P, Clave E, Janin A, Socié G.

Bone Marrow Transplant. 2013 Nov;48(12):1582. doi: 10.1038/bmt.2013.102. Epub 2013 Jul 22. No abstract available.

PMID:
23872738
19.

Thymic function recovery after unrelated donor cord blood or T-cell depleted HLA-haploidentical stem cell transplantation correlates with leukemia relapse.

Clave E, Lisini D, Douay C, Giorgiani G, Busson M, Zecca M, Moretta F, Acquafredda G, Brescia LP, Locatelli F, Toubert A.

Front Immunol. 2013 Mar 4;4:54. doi: 10.3389/fimmu.2013.00054. eCollection 2013.

20.

Age-adjusted recipient pretransplantation telomere length and treatment-related mortality after hematopoietic stem cell transplantation.

Peffault de Latour R, Calado RT, Busson M, Abrams J, Adoui N, Robin M, Larghero J, Dhedin N, Xhaard A, Clave E, Charron D, Toubert A, Loiseau P, Socié G, Young NS.

Blood. 2012 Oct 18;120(16):3353-9. doi: 10.1182/blood-2012-01-403337. Epub 2012 Sep 4.

21.

A low thymic function is associated with leukemia relapse in children given T-cell-depleted HLA-haploidentical stem cell transplantation.

Clave E, Lisini D, Douay C, Giorgiani G, Busson M, Zecca M, Charron D, Bernardo ME, Toubert A, Locatelli F.

Leukemia. 2012 Aug;26(8):1886-8. doi: 10.1038/leu.2012.59. Epub 2012 Mar 5. No abstract available.

PMID:
22430571
22.

Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: never say never again.

Toubert A, Glauzy S, Douay C, Clave E.

Tissue Antigens. 2012 Feb;79(2):83-9. doi: 10.1111/j.1399-0039.2011.01820.x. Review.

PMID:
22220718
23.

Outcomes, infections, and immune reconstitution after double cord blood transplantation in patients with high-risk hematological diseases.

Ruggeri A, Peffault de Latour R, Carmagnat M, Clave E, Douay C, Larghero J, Cayuela JM, Traineau R, Robin M, Madureira A, Ribaud P, Ferry C, Devergie A, Purtill D, Rabian C, Gluckman E, Toubert A, Socié G, Rocha V.

Transpl Infect Dis. 2011 Oct;13(5):456-65. doi: 10.1111/j.1399-3062.2011.00632.x. Epub 2011 Apr 5.

PMID:
21466640
24.

Th17/Treg ratio in human graft-versus-host disease.

Ratajczak P, Janin A, Peffault de Latour R, Leboeuf C, Desveaux A, Keyvanfar K, Robin M, Clave E, Douay C, Quinquenel A, Pichereau C, Bertheau P, Mary JY, Socié G.

Blood. 2010 Aug 19;116(7):1165-71. doi: 10.1182/blood-2009-12-255810. Epub 2010 May 18.

25.

New onset of myasthenia gravis after treatment of systemic sclerosis by autologous hematopoietic stem cell transplantation: sustained autoimmunity or inadequate reset of tolerance?

Deligny C, Clave E, Sibon D, Daikeler T, Keshmandt H, Carmagnat M, Douay C, Arfi S, Clair B, Toubert A, Farge D.

Hum Immunol. 2010 Apr;71(4):363-5. doi: 10.1016/j.humimm.2010.01.013. Epub 2010 Feb 4.

PMID:
20085795
26.

Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation.

Clave E, Busson M, Douay C, Peffault de Latour R, Berrou J, Rabian C, Carmagnat M, Rocha V, Charron D, Socié G, Toubert A.

Blood. 2009 Jun 18;113(25):6477-84. doi: 10.1182/blood-2008-09-176594. Epub 2009 Mar 3.

27.

Patterns of cytomegalovirus reactivation are associated with distinct evolutive profiles of immune reconstitution after allogeneic hematopoietic stem cell transplantation.

Moins-Teisserenc H, Busson M, Scieux C, Bajzik V, Cayuela JM, Clave E, de Latour RP, Agbalika F, Ribaud P, Robin M, Rocha V, Gluckman E, Charron D, Socié G, Toubert A.

J Infect Dis. 2008 Sep 15;198(6):818-26. doi: 10.1086/591185.

PMID:
18666855
28.

Centrosomal pre-integration latency of HIV-1 in quiescent cells.

Zamborlini A, Lehmann-Che J, Clave E, Giron ML, Tobaly-Tapiero J, Roingeard P, Emiliani S, Toubert A, de Thé H, Saïb A.

Retrovirology. 2007 Sep 10;4:63.

29.

Centrosomal latency of incoming foamy viruses in resting cells.

Lehmann-Che J, Renault N, Giron ML, Roingeard P, Clave E, Tobaly-Tapiero J, Bittoun P, Toubert A, de Thé H, Saïb A.

PLoS Pathog. 2007 May 25;3(5):e74.

30.

Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis.

Farge D, Henegar C, Carmagnat M, Daneshpouy M, Marjanovic Z, Rabian C, Ilie D, Douay C, Mounier N, Clave E, Bengoufa D, Cabane J, Marolleau JP, Gluckman E, Charron D, Toubert A.

Arthritis Rheum. 2005 May;52(5):1555-63.

31.

Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients.

Fonseca SG, Moins-Teisserenc H, Clave E, Ianni B, Nunes VL, Mady C, Iwai LK, Sette A, Sidney J, Marin ML, Goldberg AC, Guilherme L, Charron D, Toubert A, Kalil J, Cunha-Neto E.

Microbes Infect. 2005 Apr;7(4):688-97. Epub 2005 Mar 21.

PMID:
15848276
32.

Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation.

Clave E, Rocha V, Talvensaari K, Busson M, Douay C, Appert ML, Rabian C, Carmagnat M, Garnier F, Filion A, Socié G, Gluckman E, Charron D, Toubert A.

Blood. 2005 Mar 15;105(6):2608-13. Epub 2004 Nov 16.

33.

Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.

Clave E, Agbalika F, Bajzik V, Peffault de Latour R, Trillard M, Rabian C, Scieux C, Devergie A, Socié G, Ribaud P, Adès L, Ferry C, Gluckman E, Charron D, Esperou H, Toubert A, Moins-Teisserenc H.

Transplantation. 2004 Jan 15;77(1):76-84.

PMID:
14724439
34.

A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation.

Talvensaari K, Clave E, Douay C, Rabian C, Garderet L, Busson M, Garnier F, Douek D, Gluckman E, Charron D, Toubert A.

Blood. 2002 Feb 15;99(4):1458-64.

35.

New tools in assessing immune reconstitution after hematopoietic stem cell transplantation.

Toubert A, Clave E, Talvensaari K, Douay C, Charron D.

Vox Sang. 2000;78 Suppl 2:29-31. Review.

PMID:
10938923
37.
38.

Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses.

Childs R, Clave E, Contentin N, Jayasekera D, Hensel N, Leitman S, Read EJ, Carter C, Bahceci E, Young NS, Barrett AJ.

Blood. 1999 Nov 1;94(9):3234-41.

39.

Human G-CSF-mobilized CD34-positive peripheral blood progenitor cells can stimulate allogeneic T-cell responses: implications for graft rejection in mismatched transplantation.

van Rhee F, Jiang YZ, Vigue F, Kirby M, Mavroudis D, Hensel NF, Agarwala V, Clave E, Childs R, Raptis A, Sloand E, Carter C, Read EJ, Barrett J.

Br J Haematol. 1999 Jun;105(4):1014-24.

PMID:
10554815
40.

Donor-recipient polymorphism of the proteinase 3 gene: a potential target for T-cell alloresponses to myeloid leukemia.

Clave E, Molldrem J, Hensel N, Raptis A, Barrett AJ.

J Immunother. 1999 Jan;22(1):1-6.

PMID:
9924693
41.

Polymorphism in CD33 and CD34 genes: a source of minor histocompatibility antigens on haemopoietic progenitor cells?

Raptis A, Clave E, Mavroudis D, Molldrem J, Van Rhee F, Barrett AJ.

Br J Haematol. 1998 Sep;102(5):1354-8.

PMID:
9753070
42.

T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect.

Barrett AJ, Mavroudis D, Tisdale J, Molldrem J, Clave E, Dunbar C, Cottler-Fox M, Phang S, Carter C, Okunnieff P, Young NS, Read EJ.

Bone Marrow Transplant. 1998 Mar;21(6):543-51.

43.

Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units.

Molldrem JJ, Clave E, Jiang YZ, Mavroudis D, Raptis A, Hensel N, Agarwala V, Barrett AJ.

Blood. 1997 Oct 1;90(7):2529-34.

44.

Radiation-enhanced expression of interferon-inducible genes in the KG1a primitive hematopoietic cell line.

Clave E, Carosella ED, Gluckman E, Socié G.

Leukemia. 1997 Jan;11(1):114-9.

PMID:
9001426
45.

Ionizing radiation effects on the KG1a primitive hematopoietic cell line.

Clave E, Carosella ED, Gluckman E, Dubray B, Socié G.

Int J Radiat Oncol Biol Phys. 1996 Jul 1;35(4):709-19.

PMID:
8690637
46.

Multicolor flow cytometry analysis of blood cell subsets in patients given total body irradiation before bone marrow transplantation.

Clave E, Socié G, Cosset JM, Chaillet MP, Tartour E, Girinsky T, Carosella E, Fridman H, Gluckman E, Mathiot C.

Int J Radiat Oncol Biol Phys. 1995 Nov 1;33(4):881-6.

PMID:
7591898
47.

[Peritoneal tuberculosis. Occurrence in a hospital over a 7-year period].

Zulaica D, Clavé E, Torrado J, González MV, Etxebarriá M, Damiano A.

Rev Clin Esp. 1984 Jan 31;172(2):95-6. Spanish. No abstract available.

PMID:
6718782
48.

[Neoplasms in drug addicts].

Zulaica D, Arrizabalaga J, Luque R, Arriola A, Clavé E.

Med Clin (Barc). 1984 Jan 14;82(1):41-2. Spanish. No abstract available.

PMID:
6319839
49.

Supplemental Content

Support Center